1. Home
  2. CYTK vs DPZ Comparison

CYTK vs DPZ Comparison

Compare CYTK & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$72.72

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo Domino's Pizza Inc

DPZ

Domino's Pizza Inc

N/A

Current Price

$341.08

Market Cap

11.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
DPZ
Founded
1997
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
11.6B
IPO Year
2004
2004

Fundamental Metrics

Financial Performance
Metric
CYTK
DPZ
Price
$72.72
$341.08
Analyst Decision
Strong Buy
Buy
Analyst Count
19
24
Target Price
$89.26
$434.29
AVG Volume (30 Days)
1.8M
766.4K
Earning Date
05-05-2026
04-27-2026
Dividend Yield
N/A
2.40%
EPS Growth
N/A
5.27
EPS
N/A
8.21
Revenue
$13,368,000.00
$4,939,994,000.00
Revenue This Year
$7.37
$7.98
Revenue Next Year
$310.19
$3.97
P/E Ratio
N/A
$42.47
Revenue Growth
N/A
4.96
52 Week Low
$47.22
$282.00
52 Week High
$88.31
$455.57

Technical Indicators

Market Signals
Indicator
CYTK
DPZ
Relative Strength Index (RSI) 42.80 54.02
Support Level $73.34 $346.31
Resistance Level $79.73 $351.96
Average True Range (ATR) 2.22 10.99
MACD -0.38 -0.64
Stochastic Oscillator 39.09 79.03

Price Performance

Historical Comparison
CYTK
DPZ

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About DPZ Domino's Pizza Inc

Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.

Share on Social Networks: